As pharmacy costs soar, employers must rigorously evaluate PBMs. Here are ten critical questions to ensure transparency and fiduciary alignment.

Employers often select Pharmacy Benefit Managers based on misleading metrics of discounts and rebates. This article explores the underlying issues and suggests better evaluative criteria for selecting PBMs.

As pharmacy benefit management reforms advance, employers face increased pressure to ensure responsible oversight of drug purchases, emphasizing the need for fiduciary alignment.

The PBM industry faces increasing scrutiny as employers push for transparency and fiduciary accountability to manage rising drug costs.

The increasing federal scrutiny on traditional pharmacy benefit managers (PBMs) raises the urgent need for fiduciary PBMs that prioritize employers' interests and provide transparent healthcare solutions.